Updates in the treatment of gonococcal infections
Eric Urnoski1, Michelle Link Patterson
1Eric Urnoski is a clinical pharmacy specialist in critical care at Crozer-Chester Medical Center in Upland, Pa. Michelle Link Patterson is a clinical pharmacy specialist at Penn Medicine Medical Group/CCA in Radnor, Pa. The authors have disclosed no potential conflicts of interest, financial or otherwise.
Abstract:
This article highlights important changes in treatment of gonococcal infections secondary to rising infection rates, as well as increased drug-resistance to previous therapy recommendations. The article is intended to assist clinicians in both the ambulatory as well as inpatient setting when treating patients with sexually transmitted infections.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Tonsillitis II: Management
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Acute Pyelonephritis I: Introduction


